Company: REVB
Filing Date: 2025-04-04
Form Type: DRS
Source: 0001213900-25-029022
Chunk: 214

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-04-04
Form: DRS
Chunk 214
---
 on the Company’s stock price on the date of grant. The grants were granted from shares of the 2021 Plan and either vest 100% on the date of grant or vest 50% on the date of grant, with 50% vesting on the vest one year thereafter. Regaining Nasdaq Compliance As previously reported on October 16, 2024, the Company received a letter from Nasdaq notifying the Company of its noncompliance with Nasdaq Listing Rule 5550(a)(2) by failing to maintain a minimum bid price for its common stock of at least $1.00 per share for 30 consecutive business days. The Company had until February 14, 2025, to regain compliance by having a minimum closing bid price of at least $1.00 per share for at least 10 consecutive business days. On February 19, 2025 the Company received a formal notice from Nasdaq stating that the Company’s common stock will continue to be listed and traded on Nasdaq, due to the Company having regained compliance with the minimum bid price requirement, and all applicable listing standards. Class F Common Stock Warrant Exercises As of March 3, 2025, the Company received alternative cashless exercise notices for 3,064,040 Class F Common Stock Warrants to purchase 383,006shares of common stock issued in connection with the Class E Warrant Inducement.

F-27 REVELATION BIOSCIENCES, INC. Up to [•] Shares of Common Stock [•] Pre-Funded Warrants to Purchase up to [•] Shares of Common Stock and up to [•] Shares of Common Stock Underlying the Pre-Funded Warrants Up to [•] Common Stock Warrants to Purchase up to [•]Shares of Common Stock and up to [•] Shares of Common Stock Underlying the Common Stock Warrants _____________________________ PRELIMINARY PROSPECTUS _____________________________ Roth Capital Partners April, 2025

PART II. INFORMATION NOT REQUIRED IN PROSPECTUS Item 13. Other Expenses of Issuance and Distribution. The estimated expenses of the offering (assuming all shares are sold), all of which are to be paid by the Registrant, are as follows:

|                              |     | Amount |         |
|:-----------------------------|:----|:-------|--------:|
| SEC Registration Fee         |     | $      |         |
| Printing Expenses            |     |        |  20,000 |
| Accounting